Question 1

What is Paragon Biosciences?

Accepted Answer

Paragon Biosciences is a Entity.

Question 2

How often does Paragon Biosciences appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 8 articles.

Question 3

When was Paragon Biosciences first tracked by Ergen?

Accepted Answer

First tracked on Apr 03, 2026.

Question 4

When was Paragon Biosciences last mentioned in news?

Accepted Answer

Last active on Jun 10, 2026.

Question 5

What is Paragon Biosciences's current news sentiment?

Accepted Answer

Aggregate sentiment score: 50 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Paragon Biosciences in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Paragon Biosciences?

Accepted Answer

Teva acquires Emalex Biosciences for ecopipam (Jun 10, 2026, 8 articles).

Question 8

How did the "Teva acquires Emalex Biosciences for ecopipam" event impact Paragon Biosciences?

Accepted Answer

Paragon Biosciences created and supported Emalex Biosciences in advancing Ecopipam through clinical development. The acquisition of Emalex Biosciences by Sun Pharma represents a successful outcome for Paragon Biosciences' investment.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.